Articles dans des revues avec comité de lecture (78)
51.
Rothenberg, M. E., Klion, A. D., Roufosse, F., Kahn, J., Weller, P. F., & Simon, H.-U. (2008). Treatment of patients with the hypereosinophilic syndrome with mepolizumab. The New England journal of medicine, 358(12), 1215-1228. doi:10.1056/NEJMoa07081253.
Huez, S., Roufosse, F., Vachiery, J.-L., Pavelescu, A., Derumeaux, G., Wautrecht, J.-C., Cogan, E., & Naeije, R. (2007). Isolated right ventricular dysfunction in systemic sclerosis: latent pulmonary hypertension? The European respiratory journal, 30(5), 928-936. doi:10.1183/09031936.0002560756.
Vanthuyne, M., Blockmans, D., Westhovens, R., Roufosse, F., Cogan, E., Coche, E., Nzeusseu Toukap, A., Depresseux, G., & Houssiau, F. A. (2007). A pilot study of mycophenolate mofetil combined to intravenous methylprednisolone pulses and oral low-dose glucocorticoids in severe early systemic sclerosis. Clinical and Experimental Rheumatology, 25(2), 287-292.59.
Vandergheynst, F., Ocmant, A., Sordet, C., Humbel, R., Goetz, J., Roufosse, F., Cogan, E., & Sibilia, J. (2006). Anti-pm/scl antibodies in connective tissue disease: clinical and biological assessment of 14 patients. Clinical and Experimental Rheumatology, 24(2), 129-133.60.
Willard-Gallo, K., Badran, B., Ravoet, M., Zerghe, A., Burny, A., Martiat, P., Goldman, M., Roufosse, F., & Sibille, C. (2005). Defective CD3gamma gene transcription is associated with NFATc2 overexpression in the lymphocytic variant of hypereosinophilic syndrome. Experimental hematology, 33(10), 1147-1159. doi:10.1016/j.exphem.2005.06.02761.
Ravoet, M., Sibille, C., Roufosse, F., Duvillier, H., Sotiriou, C., Schandené, L., Martiat, P., Goldman, M., & Willard-Gallo, K. (2005). 6q- is an early and persistent chromosomal aberration in CD3-CD4+ T-cell clones associated with the lymphocytic variant of hypereosinophilic syndrome. Haematologica, 90(6), 753-765.